Recent findings from a global research initiative led by the University of Galway and McMaster University have revealed the impact of beverage choices and stroke risk.
Jeff Wyrtzen, Chief Marketing & Business Development Officer at Brainomix explores the impact of the e-Stroke thrombectomy platform and its implementation across the supraregional network.
Adam Nickerson, Head of Category, Digital and IT procurement frameworks at NHS Shared Business Services (NHS SBS), explains how artificial intelligence software (AI) is used to support decision making & transform outcomes for stroke patients.
Jeff Wyrtzen, Chief Marketing & Business Development Officer at Brainomix, explores a study proving that e-Stroke software improves stroke treatment rates
Jeff Wyrtzen, Chief Marketing & Business Development Officer at Brainomix reveals the findings of a new study showing that the e-Stroke software shortens treatment times, hugely benefitting stroke patients.
Richard Francis, Head of Research at the Stroke Association, identifies the priority areas for research investment that will make the greatest difference to stroke survivors.
Dr Roderick Corriveau, PhD from the National Institute of Neurological Disorders & Stroke, part of the National Institutes of Health in the U.S., details the importance of understanding the many possible paths to dementia.
L2S2 Marketing Manager Max McKiernan details the journey that led Neuro ProActive Founder, Ian Pearce, to start the development of a digital neuro rehabilitation platform.
